ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Davide Campari

Davide Campari (CPRM)

8.26
-0.234
(-2.75%)
Closed July 30 11:30AM
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
8.26
Bid
8.26
Ask
8.27
Volume
1,656,071
7.83 Day's Range 8.56
0.00 52 Week Range 0.00
Previous Close
8.494
Open
8.416
Last Trade
1472
@
8.26
Last Trade Time
Average Volume (3m)
-
Financial Volume
13,470,687 €
VWAP
8.1341

CPRM Latest News

Nu Skin Enterprises Announces 9 Percent Increase in Quarterly Dividend

PROVO, Utah, Feb. 9 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc. (NYSE:NUS) today announced that its board of directors declared a 9 percent increase in the quarterly cash dividend to...

Nu Skin Unveils Next-Generation Galvanic Spa System for Seamless Integration With ageLOC Anti-Aging Skin Care

Company Rolls Out ageLOC Product Suite with Global Tour PROVO, Utah, Jan. 15 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc. (NYSE:NUS) today announced the start of an international tour to...

Nu Skin Announces New Scientific Advisor

Stuart Kim, Ph.D., Provides Expertise on Gene-based Anti-aging Science PROVO, Utah, Jan. 11 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc. (NYSE:NUS), a premier anti-aging company, announced...

Nu Skin Celebrates Record-Breaking Global Convention

Global Launch of Anti-aging Science and Products Represents 'Sweet Spot' for Distributor Business Opportunity PROVO, Utah, Oct. 29 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc. (NYSE:NUS...

Nu Skin Announces Research Agreements With Stanford University and LifeGen Technologies

Key Scientists Collaborate With Nu Skin on Genetically-based Anti-aging Science PROVO, Utah, Oct. 22 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc. (NYSE:NUS) today announced that it has...

Nu Skin Enterprises Announces Record Revenue

PROVO, Utah, Oct. 20 /PRNewswire-FirstCall/ -- Today Nu Skin Enterprises pre-announced record quarterly revenue and earnings in advance of its 25th Anniversary Global Convention. Revenue for the...

Nu Skin Enterprises Declares Quarterly Dividend of $0.115

PROVO, Utah, Aug. 7 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc. (NYSE:NUS) today announced the board of directors has declared a quarterly dividend of $0.115 per share which will be paid...

Nu Skin Enterprises Reports Second-Quarter 2009 Results

Strong Performance Leads Company to Raise Annual Guidance PROVO, Utah, July 29 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc. (NYSE:NUS) today announced record second-quarter revenue of...

Nu Skin Chairman Recognized With 2009 International Award for Outstanding Business Performance

PROVO, Utah, July 14 /PRNewswire-FirstCall/ -- Nu Skin Enterprises' (NYSE: NUS) founder and Chairman of the Board Blake Roney was honored yesterday with the International Stevie Award as the top...

Nu Skin Child Hunger Relief Effort Surpasses 150 Million Meals

Nourish the Children(R) Promotes Sustained Food Donations PROVO, Utah, April 14 /PRNewswire-FirstCall/ -- Nu Skin Enterprises (NYSE: NUS) today announced more than 150 million meals have been...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ASAOAtlantic Sapphire ASA
kr 6.071
(20.22%)
454
ATOPAtos SE
1.007 €
(16.60%)
149.82k
EKIPEkinops
3.315 €
(10.68%)
6.68k
BIOPOCBioporto A S
kr 2.46
(10.07%)
548
RDCDRedcare Pharmacy NV
145.30 €
(8.92%)
9.72k
LOCALPSolocal Groupe
0.00555 €
(-38.33%)
2.11M
XSPRASXSpray Pharma AB
SEK 52.00
(-12.46%)
3k
INTRUSIntrum AB
SEK 44.87
(-11.39%)
88.13k
BNNDBRAIN Biotech AG
2.11 €
(-10.97%)
97
BOULSBoule Diagnostics AB
SEK 9.14
(-10.39%)
22
SASSSAS AB
SEK 0.0242
(-1.63%)
15.81M
ISPMIntesa Sanpaolo Spa
3.7975 €
(3.28%)
6.37M
TITMTelecom Italia SpA
0.2307 €
(0.74%)
2.53M
SANEBanco Santander SA
4.512 €
(0.82%)
2.25M
BCPUBanco Comercial Portugues SA
0.3864 €
(0.34%)
2.13M

Discussion

View Full Feed
Hosai Hosai 4 minutes ago
I prob was too leading in my question but gemini seems to agree that Anavex should have prob been more precise, I still think it's prob calander year but emailed IR just in-case.

"if a company has a year end of 30th september, and they talk about an event being expected to happen in Q
AVXL
PioneerCorsair42 PioneerCorsair42 4 minutes ago
There’ll be a big volume day when there’s capitulation.
SPZI
exwannabe exwannabe 4 minutes ago
The patent does not get extended.

The patent on the subQ version is a different patent with its own expiration. So the market would have generic infusion based nivolumab competing against Opdivo and Opdivo SQ.. If patients and docs prefer SQ then they have a winner.

Thi
NWBO
KVM KVM 4 minutes ago
Totally disagree. May get both but 100% sure stock offering in some form in the works.
VERI
Monksdream Monksdream 4 minutes ago
AZTR new 52 week low
https://investorshub.advfn.com/uimage/uploads/2024/7/30/wuwubIMG_0134.gif
AZTR
poster44ny poster44ny 4 minutes ago
$HHSE ANNOUNCED UPCOMING $10M FUNDING

1). LETTER OF INTENT TERMS FOR UP TO $10-MM CORPORATE FINANCING – The Board reviewed a financing proposal for the company, which was presented by a well-known and respected New York-based private equity fund (the “Special Ventures” partner). The
HHSE
WOW23P WOW23P 4 minutes ago
I think so too, Chil. Are we both dilusional? Calm before the storm (thursday morn)

Pharma Karma!!
PAYS
fink fink 4 minutes ago
No worries. I'll sell you your shares back at .015 with the shares I bought from you at .0047

I'll hold them tight for ya.
IGPK
chumfm chumfm 4 minutes ago
Roger tries to pump it up everytime he see's increased volumes.The problem is he says the same things over and over.He never answers the question about share price or dividends.Always spewing old news that amounts to nothing.This is why you are at 20 cents and falling.He will keep printing shares to
GNS
timberwolf7 timberwolf7 4 minutes ago
Notice WHO likes to say conservatives are 'weird'??
But then you take a look at the ones speaking and go....LOL

https://media.gab.com/cdn-cgi/image/width=568,quality=100,fit=scale-down/system/media_attachments/files/164/318/786/original/624e495fcaa13b9d.jpeg
jammy32 jammy32 5 minutes ago
You should add number 47 - continue to kick the can.

Look at CC from 2017. We are working toward the Nasdaq. Hmmmm
ELTP
WhatUPWhatUP WhatUPWhatUP 5 minutes ago
you should be good, because you're not buying or selling at all right?
SFRX
DTGoody DTGoody 5 minutes ago
It could be a lot worse as folks could have been holding JAGX at $4.90 per share last week and now are trading @ just over a Dollar. It's not just the OTC's that get beaten up. AFFU will be just fine in the long run. These are some great prices to be acquiring shares here.
AFFU JAGX
dstock07734 dstock07734 5 minutes ago
Agree!
NWBO
Penny Stocks 2.0 Penny Stocks 2.0 5 minutes ago
.0117 up, she's thin $ADIA
ADIA
leverage102 leverage102 5 minutes ago
NSAV $$$$$. *

Is that NSAVx , or any relation ?


NSAV DA KING CEX $$$$
NSAV
infamous infamous 6 minutes ago
yea and 86 mil OS is small for any big move above 1.00 of course! ILAL
ILAL
bob4uall bob4uall 6 minutes ago
Yes, no more BZWR stock after closing.

The July Agreement with IPSI could say that BZWR must file, but I don’t know why it would. Since they don’t intend to trade as BZWR anymore, why take the time and expense?
BZWR IPSI
Acme Investments Acme Investments 6 minutes ago
Ahhh......my old stomping ground!! Cleveland right next to Lake Erie!!
HIRU
ducci1 ducci1 6 minutes ago
Out 544C .37 !
SPY
jedijazz jedijazz 6 minutes ago
$IFUS -Impact Fusion International Inc (IFUS) Press Releases https://www.nasdaq.com/market-activity/stocks/ifus/press-releases
IFUS
ExtremelyBullishZig ExtremelyBullishZig 6 minutes ago
LOL...same old lame story. You just cannot admit that you are wrong.
AVXL
GBR GBR 6 minutes ago
Just all out neglect and indifference for the shareholder and stock price.

The only good thing I can say is that it doesn't look like a public offering is in the works. I think we see a transaction come earnings.
VERI

Your Recent History

Delayed Upgrade Clock